Journal
PANCREAS
Volume 39, Issue 1, Pages E31-E41Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPA.0b013e3181bce796
Keywords
human pancreatic adenocarcinoma; PKC delta; invasion; PI3K/AKT; ERK
Categories
Funding
- SECYT-Prestamo BID [1728/OC-AR PICT 11217, PICT 00417]
Ask authors/readers for more resources
Objective: Our objective was to study the role of protein kinase C delta (PKC delta) in the progression of human pancreatic carcinoma. Methods: Protein kinase C delta expression in human ductal carcinoma (n = 22) was studied by immunohistochemistry. We analyzed the effect of PKC delta overexpression on in vivo and in vitro properties of human ductal carcinoma cell line PANC1. Results: Human ductal carcinomas showed PKC delta overexpression compared with normal counterparts. In addition, in vitro PKC delta-PANC1 cells showed increased anchorage-independent growth and higher resistance to serum starvation and to treatment with cytotoxic drugs. Using pharmacological inhibitors, we determined that phosphatidylinositol-3-kinase and extracellular receptor kinase pathways were involved in the proliferation of PKC delta-PANC1. Interestingly, PKC delta-PANC1 cells showed a less in vitro invasive ability and an impairment in their ability to migrate and to secrete the proteolytic enzyme matrix metalloproteinase-2. In vivo experiments indicated that PKC delta-PANC1 cells were more tumorigenic, as they developed tumors with a significantly lower latency and a higher growth rate with respect to the tumors generated with control cells. Besides, only PKC delta-PANC1 cells developed lung metastasis. Conclusion: Our results showed that the overexpression of PKC delta in PANC1 cells induced a more malignant phenotype in vivo, probably through the modulation of cell proliferation and survival, involving phosphatidylinositol-3-kinase and extracellular receptor kinase signaling pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available